Janux Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 11.19 M | $302.12 M | 7.95% | 18.11% |
| FMR LLC | 05/12/2025 | 8.88 M | $239.87 M | 2.47% | 14.38% |
| JANUS HENDERSON GROUP PLC | 05/15/2025 | 4.60 M | $133.68 M | 29.07% | 7.44% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 3.65 M | $98.67 M | 19.36% | 5.91% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2025 | 3.33 M | $89.91 M | -5.29% | 5.39% |
| BLACKROCK, INC. | 05/02/2025 | 2.87 M | $77.57 M | 5.40% | 4.65% |
| VANGUARD GROUP INC | 05/09/2025 | 2.28 M | $61.52 M | 6.66% | 3.69% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2025 | 2.00 M | $54.00 M | -4.76% | 3.24% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2025 | 1.65 M | $44.55 M | 32.00% | 2.67% |
| ECOR1 CAPITAL, LLC | 05/15/2025 | 1.47 M | $39.69 M | 0.00% | 2.38% |
| WOODLINE PARTNERS LP | 05/15/2025 | 1.46 M | $39.34 M | -21.33% | 2.36% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 1.39 M | $37.61 M | 25.48% | 2.25% |
| STATE STREET CORP | 05/15/2025 | 1.37 M | $37.03 M | 8.17% | 2.22% |
| FRANKLIN RESOURCES INC | 05/13/2025 | 1.19 M | $32.03 M | 138.59% | 1.92% |
| PERCEPTIVE ADVISORS LLC | 05/15/2025 | 970.41 K | $26.20 M | 18.65% | 1.57% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 780.91 K | $21.09 M | 9.22% | 1.26% |
| ORBIMED ADVISORS LLC | 05/15/2025 | 758.57 K | $20.48 M | 0.00% | 1.23% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 749.33 K | $20.23 M | -5.72% | 1.21% |
| CITADEL ADVISORS LLC | 05/15/2025 | 706.66 K | $19.08 M | -48.07% | 1.14% |
| PROSIGHT MANAGEMENT, LP | 05/15/2025 | 689.90 K | $18.63 M | 109.21% | 1.12% |
| LORD, ABBETT & CO. LLC | 05/13/2025 | 667.88 K | $18.03 M | -47.32% | 1.08% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 05/15/2025 | 658.82 K | $17.79 M | 109.96% | 1.07% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 656.61 K | $17.73 M | 70.64% | 1.06% |
| BIOIMPACT CAPITAL LLC | 05/15/2025 | 567.19 K | $15.31 M | 146.61% | 0.92% |
| UBS GROUP AG | 05/13/2025 | 488.48 K | $13.19 M | 117.02% | 0.79% |
| FIRST TURN MANAGEMENT, LLC | 05/15/2025 | 430.16 K | $11.61 M | 12.14% | 0.70% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2025 | 408.68 K | $11.03 M | 18.49% | 0.66% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 393.48 K | $10.62 M | -26.51% | 0.64% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 376.66 K | $10.17 M | -39.38% | 0.61% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 05/06/2025 | 376.50 K | $10.17 M | -12.32% | 0.61% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 368.94 K | $9.96 M | 1,151.86% | 0.60% |
| STEMPOINT CAPITAL LP | 05/15/2025 | 342.06 K | $9.24 M | 134.49% | 0.55% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 303.19 K | $8.19 M | 32.17% | 0.49% |
| NORTHERN TRUST CORP | 05/13/2025 | 299.22 K | $8.08 M | -3.10% | 0.48% |
| ENSIGN PEAK ADVISORS, INC | 05/14/2025 | 294.75 K | $7.96 M | 107.13% | 0.48% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 286.28 K | $7.73 M | -24.73% | 0.46% |
| MORGAN STANLEY | 05/15/2025 | 282.43 K | $7.63 M | 29.65% | 0.46% |
| READYSTATE ASSET MANAGEMENT LP | 05/06/2025 | 276.56 K | $7.47 M | -18.57% | 0.45% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 273.64 K | $7.39 M | 0.19% | 0.44% |
| VICTORY CAPITAL MANAGEMENT INC | 05/02/2025 | 265.65 K | $7.17 M | 9.59% | 0.43% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 264.90 K | $7.15 M | 100.00% | 0.43% |
| AMERIPRISE FINANCIAL INC | 05/14/2025 | 261.26 K | $7.05 M | 1,652.73% | 0.42% |
| INVESCO LTD. | 05/12/2025 | 258.11 K | $6.97 M | -9.33% | 0.42% |
| AVIDITY PARTNERS MANAGEMENT LP | 05/15/2025 | 258.00 K | $6.97 M | -65.22% | 0.42% |
| ABRDN PLC | 05/13/2025 | 224.79 K | $6.07 M | 250.84% | 0.36% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2025 | 204.47 K | $5.52 M | 0.00% | 0.33% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 05/13/2025 | 192.37 K | $5.60 M | 22.63% | 0.31% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 186.39 K | $5.03 M | 12.46% | 0.30% |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 05/07/2025 | 177.82 K | $4.80 M | -13.33% | 0.29% |
| TUDOR INVESTMENT CORP ET AL | 05/15/2025 | 174.35 K | $4.71 M | 100.00% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Janux Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 228 institutional investors and hedge funds held shares of Janux Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 11.19 M
FMR LLC: 8.88 M
JANUS HENDERSON GROUP PLC: 4.6 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 3.65 M
Paradigm Biocapital Advisors LP: 3.33 M
BlackRock, Inc.: 2.87 M
107.60% of Janux Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 69.10 M shares in the last 24 months. This purchase volume represents approximately $1.72 B in transactions.